Market Closed -
Bombay S.E.
03:30:51 31/05/2024 pm IST
5-day change
1st Jan Change
753.4
INR
-0.53%
-5.21%
-1.73%
Schedule of the Results Conference Call for Q2FY22
November 12, 2021 at 08:05 pm IST
-126,NOIDA-201304, Distt.
+91120
3090111, 3090211
Gautam Budh Nagar, Uttar Pradesh, Tel.: E-mail: iglho@indiaglycols.com, Website:
+91
120 6860000, 3090100,
www.indiaglycols.com
The Manager (Listing)
BSE Limited
1st
Floor, New Trading
Ring,
Rotunda
P.J.
Towers,
Building,
Dalal Street,
Mumbai - 400 001
Scrip Code: 500201
The Manager (Listing)
National Stock Exchange of India Limited
Exchange
Block G,
Plaza, C-1,
Bandra Kurla Complex,
Bandra (East)
Mumbai-400 051
Symbol: INDIAGLYCO
Disclosure under Regulation 30 of Disclosure Requirements) Regulations, Conference Call
SEBI
(Listing
- Intimation
Obligations and of Q2FY22 Results
Regulation 30 of the Securities
and Exchange Board of India
and
Disclosure Requirements)
Regulations, 2015, we would
This
letter
is
also
www.indiaglycols.com.
rJa
Head (Legal)
(~.Q. ~
Encl: A/a
Corporate Office : 3A, Shakespeare Sarani, Kolkata - 700071,
Phone : +91
33 22823585, 22823586
Registered Office : A-1,
Industrial Area, Bazpur Road, Kashipur - 244 713, Distt. Udham Singh Nagar (Uttarakhand)
Phone: +91
5947 269000 I 269500 Fax: +915947275315,
269535
CIN:
L24111UR1983PLC009097
is pleased to invite you to the
Q2FY22 Results Conference Call
of
India Glycols Ltd
CIN: L24111UR1983PLC009097
Represented by
Mr. Sudhir Agarwal, Executive Director
Mr. Rupark Sarswat, Chief Executive Officer
Mr. Anand Singhal, Chief Financial Officer Mr. Sanjeev Gurwara, President - Marketing Mr. S.K. Shukla, Head - Liquor Business
Prof. Dr. R.K. Khandal, President - R&D and Business Development Mr. Ankur Jain, Head (Legal) & Company Secretary
on
Tuesday, November 16, 2021
At 15:30 hrs India Time
Diamond Pass registration link:
Copy this Link in your browser: Link
Call Co-ordinator
Mr. Sanjesh Jain: Phone: +91 22 6807 7153, e-mail:sanjesh.jain@icicisecurities.com
For any clarification, please contact:
Mr. Rushad Kapadia: Phone: +91 22 6807 7334, e-mail: rushad.kapadia@icicisecurities.com Ms. Divya Purohit: Phone: +91 22 6807 7454, e-mail: divya.purohit@icicisecurities.com
Ms. Seema Sehgal: Phone: +91 11 4221 8511, e-mail:seema.sehgal@icicisecurities.com
Attachments
Original document
Permalink
Disclaimer
India Glycols Ltd. published this content on 12 November 2021 and is solely responsible for the information contained therein. Distributed by Public , unedited and unaltered, on 12 November 2021 14:33:09 UTC .
Transcript : India Glycols Limited, Q4 2024 Earnings Call, May 30, 2024
30/05
India Glycols Limited Recommends Dividend for the Financial Year Ended 31St March, 2024
28/05
CI
India Glycols Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2024
28/05
CI
India Glycols Limited Reports Earnings Results for the Full Year Ended March 31, 2024
28/05
CI
India Glycols Limited Receives Order from Additional Commissioner, Noida Customs Commissionerate, Uttar Pradesh
09/04
CI
India Glycols Limited Announces Resignation of Manu Raj V as Plant head of IGL - Ennature Bio Pharma division
02/04
CI
India Glycols Limited Announces Update on Enhancement of Capacity of Grain Based Distillery and Facilities/Project for New Specialty Chemicals
31/03
CI
India Glycols Limited Provides Update on Enhancement of Capacity of Bio-Fuel Ethanol Plant At Kashipur (Uttarakhand)
07/03
CI
Transcript : India Glycols Limited, Q3 2024 Earnings Call, Feb 05, 2024
05/02
India Glycols Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023
02/02
CI
India Glycols Completes Capacity Expansion at Grain-Based Distillery in Uttarakhand, India
27/12
MT
Faith Mercantile Private Limited, Meir Commodities India Private Limited and R.K.& D Investment Private Limited completed the acquisition of 98.885% stake in Shakumbari Sugar And Allied Industries Limited from India Glycols Limited and others.
15/12
CI
India Glycols Limited Announce Cessation of Sudhir Agarwal as Director/Executive Director
01/12
CI
India Glycols Limited Appoints Shri Vishal Shishodia as Head - Imfl (Sales & Marketing)
03/11
CI
India Glycols Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023
03/11
CI
India Glycols Limited Announces Cessation of Tejinder Paul Sharma as Head IMFL (Sales & Marketing)
12/23/12
CI
India Glycols Limited Announces Resignation of Dipankar Mukherjee as Head - Technical Services
17/23/17
CI
India Glycols Limited Announces Expansion of Facility for New Value-Added Chemical Products
07/23/07
CI
India Glycols Limited Reports Earnings Results for the First Quarter Ended June 30, 2023
07/23/07
CI
India Glycols Limited Recommends Dividend for the Financial Year Ended 31 March, 2023
24/23/24
CI
India Glycols Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2023
24/23/24
CI
India Glycols Limited Announces Cessation of Sajeve Bhushan Deora as an Independent Director
01/23/01
CI
Faith Mercantile Private Limited, Meir Commodities India Private Limited and R.K.& D Investment Private Limited agreed to acquire 98.885% stake in Shakumbari Sugar And Allied Industries Limited from India Glycols Limited and others for INR 6.01 million.
30/23/30
CI
Gateway Distriparks Completes Acquisition of Indian Rail-Connected Container Depot
26/22/26
MT
Gateway Distriparks Limited completed the acquisition of 99.92% stake in Kashipur Infrastructure And Freight Terminal Private Limited from Apollo Logisolutions Limited, India Glycols Limited and Kashipur Holdings Limited.
23/22/23
CI
Duration Auto. 2 months 3 months 6 months 9 months 1 year 2 years 5 years 10 years Max.
Period Day Week
More charts
India Glycols Limited is an India-based company, which is engaged in manufacturing green technology-based bulk, specialty and performance chemicals and natural gums, spirits, industrial gases, sugar and nutraceuticals. The Company's segments include Bio-based Specialities and Performance Chemicals, Potable Spirits, and Ennature Biopharma. The Bio-based Specialities and Performance Chemicals segment comprises glycols, specialty chemicals, natural gum and other related goods. The Potable Spirits segment is engaged in the manufacturing and sale of ethyl alcohol (potable). The Ennature Biopharma segment is engaged in the manufacturing and sale of nutraceutical products. It has a product range that covers a variety of specialties and herbal products, such as nutraceuticals, phytochemicals, biopolymers, mainly Polygalactomannans, industrial gases and liquor. It serves various industries, such as automotive, detergents, healthcare and food processing, mining, and oil and gas, among others.
More about the company
1st Jan change
Capi.
-1.73% 280M +2.46% 102B -8.98% 60.79B +74.76% 48.86B +13.97% 37.96B +4.56% 32.37B +14.72% 20.64B +11.17% 16.58B +8.81% 13.93B -3.19% 13.25B
Other Commodity Chemicals
+951% of historical performance
More than 20 years at your side
Our Experts are here for you
OUR EXPERTS ARE HERE FOR YOU
Monday - Friday 9am-12pm / 2pm-6pm GMT + 1